Dr. Klaff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 N Waukegan Rd
Bldg AP31
Abbott Park, IL 60064
Education & Training
Johns Hopkins UniversityFellowship, Burn Surgery, 2010 - 2012
Virginia Commonwealth University Health SystemResidency, Surgery, 2005 - 2007
Tel Aviv University SacklerClass of 2005
Certifications & Licensure
MD State Medical License 2012 - 2026
VA State Medical License 2008 - 2026
Publications & Presentations
PubMed
- 9 citationsEfficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitis.Remo Panaccione, Silvio Danese, Wen Zhou, Justin Klaff, Dapo Ilo
Alimentary Pharmacology & Therapeutics. 2024-02-01 - 3 citationsEfficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHI...Séverine Vermeire, Silvio Danese, Wen Zhou, Dapo Ilo, Justin Klaff
The Lancet. Gastroenterology & Hepatology. 2023-11-01 - 2 citationsLong-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study.Alan Kivitz, Alvin F Wells, Juan I Vargas, Herbert S B Baraf, Maureen Rischmueller
Rheumatology and Therapy. 2023-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
